CCN2 and breast cancer: For instance, CTGF over-expression has been positively correlated with aggressive behavior of gastric, pancreatic and breast cancer [26–28], whereas it was shown to inhibit metastasis and invasion of colorectal cancer and lung adenocarcinoma [29, 30].